Soluble Programmed Death Receptor Ligands sPD-L1 and sPD-L2 as Liquid Biopsy Markers for Prognosis and Platinum Response in Epithelial Ovarian Cancer

Introduction: Response to platinum-based therapy is a major prognostic factor in epithelial ovarian cancer (EOC) and reliable prognostic biomarkers are urgently needed to identify patients at high risk. Since ligands of the Programmed Death Receptor-1 (PD-L1 and PD-L2) play a crucial role within the...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Paul Buderath, Esther Schwich, Christina Jensen, Peter A. Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebmann
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Frontiers Media S.A. 2019-10-01
Cyfres:	Frontiers in Oncology
Pynciau:	epithelial ovarian cancer (EOC) soluble PD-L1 (sPD-L1) soluble PD-L2 (sPD-L2) liquid biopsy biomarkers platinum therapy
Mynediad Ar-lein:	https://www.frontiersin.org/article/10.3389/fonc.2019.01015/full
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!